Treatment of the hyperlipidemic states with special emphasis on the place of cholestyramine in therapy.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001835:Body Weight; D002648:Child; D002784:Cholesterol / Q000097:blood; D002792:Cholestyramine Resin / Q000627:therapeutic use*; D002994:Clofibrate / Q000627:therapeutic use; D003918:Dextrothyroxine / Q000627:therapeutic use; D004035:Diet Therapy; D004038:Diet, Reducing; D004040:Dietary Carbohydrates; D004041:Dietary Fats; D004044:Dietary Proteins; D004586:Electrophoresis; D005224:Fats, Unsaturated; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000145:classification / Q000188:drug therapy / Q000628:therapy*; D008074:Lipoproteins / Q000032:analysis; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use; D014280:Triglycerides / Q000097:blood
D004040:Dietary Carbohydrates; D004041:Dietary Fats; D004044:Dietary Proteins; D005224:Fats, Unsaturated; D008074:Lipoproteins; D009539:Nicotinic Acids; D014280:Triglycerides; D002792:Cholestyramine Resin; D003918:Dextrothyroxine; D002784:Cholesterol; D002994:Clofibrate